Prostate-specific membrane antigen PET response associates with radiographic progression-free survival following stereotactic ablative radiation therapy in oligometastatic castration-sensitive prostate cancer.
Tarih
2022Yazar
Sutera, Philip
Deek, Matthew
Guler, Ozan Cem
Hurmuz, Pervin
Reyhan, Mehmet
Rowe, Steven P.
Hrinivich, William
Ren, Lei
Kiess, Ana Ponce
Song, Daniel Y.
Oymak, Ezgi
Pienta, Kenneth J.
Pomper, Martin
Feng, Felix Y.
Ozyigit, Gokhan
Tran, Phuoc T.
Phillips, Ryan
Onal, Huseyin Cem